Watson Pharmaceuticals

                   

Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL 150 mg

pharmiweb.co.uk
13 hrs ago
        

CORONA, Calif., November 26, 2008 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval...

add comment

Big Pharma's Patent Headache

businessweek.com
yesterday 97 related
        

In 2008 more than 10 top-selling drugs will lose patent protection. The industry hopes to recoup the losses with authorized generics Women with brittle bones could be in for a bit of a windfall come Feb. 6. That's when Merck's...

add comment

Watson says FDA approves its generic Wellbutrin XL

ibtimes.com
Nov 26, 2008 13 related
        

Watson Pharmaceuticals Inc. said Wednesday it has received approval to market its generic version of the 150 mg dose of antidepressant Wellbutrin XL. Watson said the Food and Drug Administration approved its Abbreviated New...

add comment

Israel Stocks: CORRECT: Market lower; Teva settles with AstraZeneca

marketwatch.com
Nov 27, 2008 59 related
        

Israeli stocks fell on Wednesday, led by some key technology names, a giveback in the real-estate index after a couple of strong days and a dip in Bank Leumi shares before it reports earnings on Thursday.

add comment

Watson to buy Teva drugs for $36 million

ibtimes.com
Nov 25, 2008 16 related
        

Watson Pharmaceuticals Inc. said Tuesday it will pay $36 million for a portfolio of generic drugs from rival Teva Pharmaceutical Industries Ltd., as that company closes its buyout of Barr Pharmaceuticals Inc.

add comment
                   

Recordati files MAA application for BPH drug in EU

pharmaceutical-business-review.com
Nov 25, 2008
        

Italy-based pharmaceutical company Recordati has submitted a marketing approval authorization request for silodosin, a new compound indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia, to the...

add comment
                   

Covidien and Depomed Announce License Agreement (Business Wire)

yahoo.com
Nov 24, 2008 1 related
        

ST. LOUIS & MENLO PARK, Calif.----Covidien and Depomed, Inc. today announced that Covidien has licensed worldwide rights from Depomed to utilize Depomed’s AcuFormTM gastric retentive drug delivery technology for the exclusive...

add comment
                   

Recordati S.p.A. SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA

pr-usa.net
Nov 23, 2008
        

RECORDATI SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA Milan, 21 November 2008 - Recordati announces that it has submitted a marketing approval authorization (MAA) request for silodosin, a new compound indicated for the...

add comment
                   

Depomed Signs $395M Deal with Solvay for Phase III Pain Drug

tmcnet.com
Nov 21, 2008 10 related
        

Depomed Inc. granted an exclusive license to Solvay Pharmaceuticals Inc. for North American rights to DM-1796 (formerly Gabapentin GR) in pain indications. The drug - an extended-release version of the active ingredient in...

add comment
                   

Recordati S.p.A. SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA

marketwire.com
Nov 21, 2008 4 related
        

MILAN, ITALY--(Marketwire - November 21, 2008) - RECORDATI SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA Milan, 21 November 2008 - Recordati announces that it has submitted a marketing approval authorization (MAA) request...

add comment
1 2 next